CARTO® 3 System and Real Time Intracardiac Ultrasound

NCT01716663 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 234

Last updated 2014-12-01

Study results available
· View outcomes & findings →

Summary

This is a prospective, multicenter, non-randomized observational study of subjects 18 years and older undergoing RF ablation with drug refractory recurrent symptomatic paroxysmal Atrial Fibrillation (AF).

Conditions

Interventions

DEVICE

Catheter Ablation

NAVISTAR® THERMOCOOL® SF Catheter with the CARTO® 3 System and the SOUNDSTAR® Ultrasound Catheter (with the CARTOSOUND® Software Module)

Sponsors & Collaborators

  • Biosense Webster, Inc.

    lead INDUSTRY

Principal Investigators

  • Usman Siddiqui, MD · Osceola Regional Medical Center

  • Mathew Hutchinson, MD · University of Pennsylvania

  • Andy Tran, MD · Scottsdale Healthcare Research

  • Saumil Oza, MD · East Coast Institute for Research LLC, St. Vincent's Ambulatory Care, Inc.

  • Robert Fishel, MD · JFK Medical Center

  • Vijendra Swarup, MD · AZ Heart Rhythm Research Center

  • Mohit Rastogi, MD · Washington Adventist Hospital CCVR

  • Brett Gidney, MD · Santa Barbara Cottage Hospital

  • John Scherschel, MD · University of Nebraska

  • Dilip Mathew, MD · Pepin Heart Hospital

  • William Sauer, MD · University of Colorado, Denver

  • Marcie Berger, MD · Medical College of Wisconsin

  • Khawaja Baig, MD · Kettering Medical Center

  • Farhat Khairallah, MD · Tallahassee Research Institute

  • David Fitzgerald, MD · Scott & White Memorial Hospital

  • Gopi Dandamudi, MD · Geisinger Heart Institute

  • Ahmad Abdul-Karim, MD · Provena St. Joseph Medical Center

  • Douglas Esberg, MD · Main Line Health

  • Scott Burke, MD · St. Mary's Medical Center

  • Gregory Jones, MD · Wellmont CVA Heart Institute

  • Tapan Rami, MD · The Methodist Hospital Research Institute

  • Salem Sayar, MD · Northeast Georgia Heart Center, PC

  • Gunjan Shukla, MD · Hackensack Meridian Health

  • Philip Gentlesk, MD · Sentara Norfolk General Hospital

  • Asim Yunus, MD · Michigan CardioVascular Institute

  • Scott Reich, MD · Northeast Baptist Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01716663 on ClinicalTrials.gov